Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision history shows the addition of v3.3.2 and the removal of v3.3.1 for the page. This reflects an internal site update to the Record History view.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding and operating status banner was removed from the page, a non-critical change that does not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedNew version entries were added to the study record history, reflecting updated submission dates, but there are no visible changes to the study design, eligibility, status, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check79 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new release/version update.SummaryDifference0.3%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.